Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.46
Delayed Data
As of 4:00pm ET
 -0.11 / -1.28%
Today’s Change
5.23
Today|||52-Week Range
16.30
+18.16%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close8.57
Today’s open8.39
Day’s range8.38 - 8.60
Volume394,502
Average volume (3 months)685,107
Market cap$343.8M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...+0.05+3.52%
PRTKParatek Pharmaceutic...-0.25-1.63%
FOMXFoamix Pharmaceutica...+0.12+1.27%
OMEDOncoMed Pharmaceutic...+0.17+1.90%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 10, 2017
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts


Search for Jobs